ARCHIVES

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study

June 29, 2012

CCIRC Loses Policy Making, Protocol Review

September 26, 1975

UNM Cancer Center Appoints Four Leaders

May 24, 2013

Lymphatic Mapping Techniques Can Outperform “Watch-and-Wait”

February 28, 2014

Regular NSAIDs Use Protects Smokers From Lung Cancer

March 28, 2003

Minna To Direct Howard Simmons Cancer Center At Texas Southwestern; ‘Major Loss’ for NCI

March 1, 1991